The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 24, 2020

Filed:

Mar. 04, 2016
Applicant:

Chase Pharmaceuticals Corporation, Parsippany, NJ (US);

Inventors:

Thomas N. Chase, Washington, DC (US);

Kathleen E. Clarence-Smith, Washington, DC (US);

Assignee:

Chase Pharmaceuticals Corporation, Parsippany, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/216 (2006.01); A61K 45/06 (2006.01); A61K 31/439 (2006.01); A61K 31/4439 (2006.01); A61K 9/70 (2006.01);
U.S. Cl.
CPC ...
A61K 31/216 (2013.01); A61K 9/703 (2013.01); A61K 31/439 (2013.01); A61K 31/4439 (2013.01); A61K 45/06 (2013.01); A61K 2300/00 (2013.01);
Abstract

Pharmaceutical compositions and combinations containing a muscarinic receptor antagonist, such as oxybutynin in a transdermal therapeutic system, and a muscarinic receptor agonist, optionally with an acetyl cholinesterase inhibitor, and methods of using the same for treatment of hypocholinergic disorders of the central nervous system such as Alzheimer type dementia. The respective pharmaceutical compositions and combinations of the present invention allow for safe administration of high doses of muscarinic receptor agonist, and improved efficacy of the muscarinic receptor agonist for treatment of hypocholinergic disorders of the central nervous system. The pharmaceutical compositions and combinations also allow for a maximum supply of acetylcholine to the central nervous system, when an acetyl cholinesterase inhibitor is used in combination with a muscarinic receptor antagonist and a muscarinic receptor agonist.


Find Patent Forward Citations

Loading…